These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 592096)
21. [ON THE ACTION OF LIPOPROTEINS IN DIABETICS UNDER TREATMENT WITH BIGUANIDES]. SANWALD R; WAHL P Schweiz Med Wochenschr; 1964 Oct; 94():1459-60. PubMed ID: 14322731 [No Abstract] [Full Text] [Related]
22. [MECHANISM OF ACTION OF ANTIDIABETIC BIGUANIDES]. STERNE J Presse Med (1893); 1964 Jan; 72():17-9. PubMed ID: 14102457 [No Abstract] [Full Text] [Related]
23. Fluorometric determination of biguanides in serum by high-performance liquid chromatography with reagent-containing mobile phase. Kobayashi Y; Kubo H; Kinoshita T; Nishikawa T J Chromatogr; 1988 Aug; 430(1):65-71. PubMed ID: 3215962 [TBL] [Abstract][Full Text] [Related]
24. Mechanism and specificity of the phenanthrenequinone test for monosubstituted guanidines. Itano HA; Hirota K; Kawasaki I; Yamada S Anal Biochem; 1976 Nov; 76(l):134-47. PubMed ID: 998960 [No Abstract] [Full Text] [Related]
25. Pharmacology of certain antimicrobial N1, N5-substituted biguanides. GALE GR; WELCH M; HYNES JB J Pharmacol Exp Ther; 1962 Nov; 138():277-84. PubMed ID: 13946228 [No Abstract] [Full Text] [Related]
26. [The paper chromatographic separaton of guanidine derivatives (author's transl)]. Ksiazek A; Jusiak J Ann Univ Mariae Curie Sklodowska Med; 1976; 31():273-9. PubMed ID: 1032789 [No Abstract] [Full Text] [Related]
27. [The importance of chlorpropamide or p.607 employed alone or in association with biguanides in the treatment of diabetes mellitus]. PLAUCHU M J Med Lyon; 1963 Jan; 44():3-12. PubMed ID: 13943997 [No Abstract] [Full Text] [Related]
28. [ON THE CLINICAL ADJUSTABILITY OF VARIOUS FORMS OF DIABETES IN DELAYED-ACTION INSULIN THERAPY, COMBINED AND EXCLUSIVELY ORAL THERAPY WITH SULFONYLUREA DERIVATIVES AND BIGUANIDES]. KNICK B; FOLKERT F Munch Med Wochenschr; 1965 Jan; 107():83-8. PubMed ID: 14301179 [No Abstract] [Full Text] [Related]
29. [Biguanides in the treatment of diabetes mellitus (author's transl)]. Dub O Cas Lek Cesk; 1978 Dec; 117(51):1595-8. PubMed ID: 743727 [No Abstract] [Full Text] [Related]
30. [WHERE IS THE QUESTION OF DIABETES MELLITUS?PHYSIOLOGICAL AND PATHOGENIC ASPECTS, CLINICAL ASPECTS OF NON-SULFONAMIDE CHEMOTHERAPY (BIGUANIDES)]. DABIS G Gaz Med Fr; 1964 Jul; 71():2573-7. PubMed ID: 14177549 [No Abstract] [Full Text] [Related]
31. [Insulin secretion of the pancreas in extracorporeal perfusion. II. Perfusions of the pancreas with periston, glucose, carbutamide and biguanides]. MEHNERT H; SCHAEFER G; KALIAMPETSOS G; STUHLFAUTH K; ENGELHARDT W Klin Wochenschr; 1962 Nov; 40():1146-51. PubMed ID: 13934503 [No Abstract] [Full Text] [Related]
32. [Studies on the hydrazone derivatives in fluorometric analysis. III. Relationships between fluorescence development of hydrazone derivatives, formation of its fluorescent metal complexes and their structures (author's transl)]. Taniguchi H; Tsuge K; Nakano S Yakugaku Zasshi; 1974 Jun; 94(6):759-65. PubMed ID: 4472641 [No Abstract] [Full Text] [Related]
34. The synthesis of p-guanidinobenzamidines. Bauer VJ; Safir SR J Med Chem; 1966 Mar; 9(2):244-6. PubMed ID: 5911806 [No Abstract] [Full Text] [Related]
35. Guanidines and biguanides. Schäfer G Pharmacol Ther; 1980; 8(2):275-95. PubMed ID: 6446091 [No Abstract] [Full Text] [Related]
36. Quantitative analysis of methylguanidine and guanidine in physiologic fluids by high-performance liquid chromatography-fluorescence detection method. Yamamoto Y; Saito A; Manji T; Maeda K; Ohta K J Chromatogr; 1979 Jan; 162(1):23-9. PubMed ID: 33192 [TBL] [Abstract][Full Text] [Related]
37. [ON THE EFFECT OF BIGUANIDES AND CHLORPROPAMIDE IN THE TREATMENT OF DIABETES MELLITUS OCCURRING AFTER SUBTOTAL RESECTION OF THE PANCREAS FOR INSULOMA]. ZEFIROVA GS; RADUGINA LP; SHMIDT SI Probl Endokrinol Gormonoter; 1964; 10():15-7. PubMed ID: 14210101 [No Abstract] [Full Text] [Related]
38. [Studies on fluorometric analysis of phenol derivatives. III. Fluorometric determination of acetaminophen. (2) Fluorometric analysis of p-aminophenol and its applycation to determination of acetaminophen (author's transl)]. Kaito T; Sagara K Yakugaku Zasshi; 1974 May; 94(5):639-44. PubMed ID: 4472619 [No Abstract] [Full Text] [Related]
39. [CHLORPROPAMIDE AND PHENETHYLBIGUANIDE ASSOCIATED WITH INSULIN THERAPY IN SOME CASES OF INSULIN RESISTANCE]. CARLETTI D Gazz Med Ital; 1965 Feb; 124():63-5. PubMed ID: 14308976 [No Abstract] [Full Text] [Related]
40. [TRIALS IN THE USE OF VIRUSMIN (ABOB) IN THE FIELD OF DERMATOLOGY]. TACHIBANA K; TAKEDA T Hifuka Kiyo; 1964 Nov; 59():284-5. PubMed ID: 14252542 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]